Company Daito Pharmaceutical Co.,Ltd.

Equities

4577

JP3486150000

Pharmaceuticals

Delayed Japan Exchange 02:00:00 2024-05-07 am EDT 5-day change 1st Jan Change
2,542 JPY +1.60% Intraday chart for Daito Pharmaceutical Co.,Ltd. +0.67% +33.44%

Business Summary

Daito Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the pharmaceutical ingredients and formulation business, as well as healthy food. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Number of employees: 1,011

Sales per Business

JPY in Million2022Weight2023Weight Delta
Formulation
57.9 %
23,703 54.5 % 26,097 57.9 % +10.10%
Drug Substance
41.6 %
19,481 44.8 % 18,783 41.6 % -3.58%
Healthy Food
0.5 %
279 0.6 % 220 0.5 % -21.15%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
43,464 100.0 % 45,101 100.0 % +3.77%

Managers

Managers TitleAgeSince
President - -
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director/Board Member 67 23-06-30
Director/Board Member 62 85-03-31
Director/Board Member 74 10-02-28
Director/Board Member 76 71-03-31
Director/Board Member 73 75-02-28
Corporate Officer/Principal - Dec. 31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 73 75-02-28
Director/Board Member 76 71-03-31
Director/Board Member 70 99-01-31
Director/Board Member 74 10-02-28
President - -
Director/Board Member 67 12-07-31
Director/Board Member 50 16-07-31
Director/Board Member 62 85-03-31
Director/Board Member 67 23-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 15,698,440 12,566,706 ( 80.05 %) 55,050 ( 0.3507 %) 80.05 %

Shareholders

NameEquities%Valuation
Kaname Capital LP (Investment Management)
6.783 %
1,064,800 6.783 % 16 M ¥
MFS International Singapore Pte. Ltd.
4.435 %
696,190 4.435 % 11 M ¥
Highclere International Investors LLP
4.006 %
628,870 4.006 % 10 M ¥
365,605 2.329 % 6 M ¥
352,107 2.243 % 5 M ¥
Portfolia, Inc.
1.994 %
312,950 1.994 % 5 M ¥
Daito Pharmaceutical Employee Stock Ownership Plan
1.828 %
286,957 1.828 % 4 M ¥
Kuwait Investment Authority (Investment Management)
1.649 %
258,830 1.649 % 4 M ¥
Ichiyoshi Asset Management Co., Ltd.
1.439 %
225,940 1.439 % 3 M ¥
Naigai Estate Co.
1.424 %
223,528 1.424 % 3 M ¥

Holdings

NameEquities%Valuation
163,500 0.01% 5,160,657 $
80,400 0.00% 2,498,406 $
61,100 0.00% 1,689,137 $
80,000 0.02% 1,297,433 $
181,037 0.28% 1,141,163 $
41,500 0.09% 948,485 $
19,200 0.04% 764,981 $
39,200 0.12% 667,730 $
30,300 0.06% 581,395 $
35,905 0.03% 459,770 $

Company contact information

Daito Pharmaceutical Co., Ltd.

326 Yokamachi

939-8567, Toyama

+

http://www.daitonet.co.jp
address Daito Pharmaceutical Co.,Ltd.(4577)
  1. Stock Market
  2. Equities
  3. 4577 Stock
  4. Company Daito Pharmaceutical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW